ProUroCare seeks FDA approval for prostate cancer monitoring device

11/29/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

ProUroCare Medical has submitted an application to the FDA seeking approval for a device that can generate 3-D images of the prostate gland to track prostate cancer. The startup firm said its technology quantifies tissue elasticity to enable physicians to conduct preliminary biopsies and monitor cancer progression.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID